State Street Corp Talis Biomedical Corp Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.44 - $0.54 $924 - $1,134	-2,100 Reduced 4.24%	47,436 $22,000
Q3 2022 Nov 15, 2022	SELL	$0.7 - $10.79 $667 - $10,293	-954 Reduced 1.89%	49,536 $34,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.44 $162,907 - $289,612	-201,120 Reduced 79.93%	50,490 $41,000
Q1 2022 May 16, 2022	SELL	$1.3 - $4.19 $19,106 - $61,580	-14,697 Reduced 5.52%	251,610 $355,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.17 $105,613 - $171,032	27,720 Added 11.62%	266,307 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$6.02 - $12.46 $196,625 - $406,968	32,662 Added 15.86%	238,587 $1.49 Million
Q2 2021 Aug 16, 2021	BUY	$9.62 - $14.56 $566,213 - $856,972	58,858 Added 40.02%	205,925 $2.27 Million
Q1 2021 May 17, 2021	BUY	$11.2 - $27.8 $1.65 Million - $4.09 Million	147,067 New	147,067 $1.89 Million

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.6M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.